Role of an MDM4 polymorphism in the early age of onset of nasopharyngeal carcinoma

Oncology Letters

Volumn 3, Issue 5, 2012, Pages 1115-1118

  Zhang, Yao Wei ^a   Guan, Jian ^a   Zhang, Yong ^b   Qiu, Yu Rong ^a   Chen, Long Hua ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

Author keywords

Case control; Genetic; Molecular epidemiology; Susceptibility

Indexed keywords

PROTEIN MDMX;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; ONSET AGE;

EID: 84863276488     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.630     Document Type: Article

References (18)

1. Wei KR, Yu YL, Yang YY, Ji MF, Yu BH, Liang ZH and Reng X: Epidemiological trends of nasopharyngeal carcinoma in China. Asian Pac J Cancer Prev 11: 29-32, 2010.
2. Zhou G, Zhai Y, Cui Y, Zhang X, Dong X, Yang H, He Y, Yao K, Zhang H, Zhi L, et al: MDM2 promoter SNP309 is associated with risk of occurrence and advanced lymph node metastasis of nasopharyngeal carcinoma in Chinese population. Clin Cancer Res 13: 2627-2633, 2007.
3. Li Y, Fu L, Wong AM, Fan YH, Li MX, Bei JX, Jia WH, Zeng YX, Chan D, Cheung KM, et al: Identification of genes with allelic imbalance on 6p associated with nasopharyngeal carcinoma in southern Chinese. PLoS One 6: e14562, 2011.
4. Xiao M, Zhang L, Zhu X, Huang J, Jiang H, Hu S and Liu Y: Genetic polymorphisms of MDM2 and TP53 genes are associated with risk of nasopharyngeal carcinoma in a Chinese population. BMC Cancer 10: 147, 2010.
5. Yu H, Huang YJ, Liu Z, Wang LE, Li G, Sturgis EM, Johnson DG and Wei Q: Effects of MDM2 promoter polymorphisms and p53 codon 72 polymorphism on risk and age at onset of squamous cell carcinoma of the head and neck. Mol Carcinog 50: 697-706, 2011.
6. Markey MP: Regulation of MDM4. Front Biosci 16: 1144-1156, 2011.
7. Yu H, Wang LE, Liu Z, Wei S, Li G, Sturgis EM and Wei Q: Polymorphisms of MDM4 and risk of squamous cell carcinoma of the head and neck. Pharmacogenet Genomics 21: 388-396, 2011.
8. Kulkarni DA, Vazquez A, Haffty BG, Bandera EV, Hu W, Sun YY, Toppmeyer DL, Levine AJ and Hirshfield KM: A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer. Carcinogenesis 30: 1910-1915, 2009.
9. Fang S, Krahe R, Lozano G, Han Y, Chen W, Post SM, Zhang B, Wilson CD, Bachinski LL, Strong LC and Amos CI: Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations. PLoS One 5: e10813, 2010.
10. Huang SF, Chen IH, Liao CT, Wang HM, Liou SH and Hsieh LL: Combined effects of MDM2 SNP 309 and p53 mutation on oral squamous cell carcinomas associated with areca quid chewing. Oral Oncol 45: 16-22, 2009.
11. Toledo F and Wahl GM: MDM2 and MDM4: p53 regulators as targets in anticancer therapy. Int J Biochem Cell Biol 39: 1476-1482, 2007.
12. Ménendez S, Goh AM, Camus S, Ng KW, Kua N, Badal V and Lane DP: MDM4 downregulates p53 transcriptional activity and response to stress during differentiation. Cell Cycle 10: 1100-1108, 2011.
13. Mancini F, Gentiletti F, D'Angelo M, Giglio S, Nanni S, D'Angelo C, Farsetti A, Citro G, Sacchi A, Pontecorvi A and Moretti F: MDM4 (MDMX) overexpression enhances stabilization of stress-induced p53 and promotes apoptosis. J Biol Chem 279: 8169-8180, 2004.
14. Atwal GS, Kirchhoff T, Bond EE, Montagna M, Menin C, Bertorelle R, Scaini MC, Bartel F, Bohnke A, Pempe C, et al: Altered tumor formation and evolutionary selection of genetic variants in the human MDM4 oncogene. Proc Natl Acad Sci USA 106: 10236-10241, 2009.
15. Nichols HB, Trentham-Dietz A, Hampton JM, Titus-Ernstoff L, Egan KM, Willett WC and Newcomb PA: From menarche to menopause: trends among US Women born from 1912 to 1969. Am J Epidemiol 164: 1003-1011, 2006.
16. Chang ET and Adami HO: The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 15: 1765-1777, 2006.
17. Tse KP, Su WH, Yang ML, Cheng HY, Tsang NM, Chang KP, Hao SP, Yao SY and Chang YS: A gender-specific association of CNV at 6p21.3 with NPC susceptibility. Hum Mol Genet 20: 2889-2896, 2011.
18. Suda T, Yoshihara M, Nakamura Y, Sekiguchi H, Godai TI, Sugano N, Tsuchida K, Shiozawa M, Sakuma Y, Tsuchiya E, et al: Rare MDM4 gene amplification in colorectal cancer: The principle of a mutually exclusive relationship between MDM alteration and TP53 inactivation is not applicable. Oncol Rep 26: 49-54, 2011.